Clinical trials
General Population (no Specific Condition or Disease) clinical trials
Below are recruiting general population (no specific condition or disease) clinical trials, each written for real people, not researchers. We’re tracking 10,565 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT02180178Recruiting
Heart catheter registry for slow coronary blood flow
This study builds a database of people who are having a coronary angiography (a heart blood-vessel X-ray test). It aims to better understand conditions like slow blood flow in the heart’s small vessels and may help improve how these conditions are diagnosed and treated.
MainzAges Any age - NCT07732010RecruitingPhase 4
Tryptophan for dry eye disease
This trial tests whether a dietary supplement called TRYPTYR can improve dry eye symptoms. You may qualify if you have moderate dry eye with certain signs, like short tear breakup time and staining on your eye surface.
New York, New YorkAges 18 years+ - NCT07724184Recruiting
Treating calcified heart arteries with a stent
This trial tests a way to treat hardened, calcified heart artery blockages using a stent. It may help people who have moderate blockages that haven't been treated before.
AalborgAges 18–90 - NCT07731191Recruiting
Digital tools to predict Alzheimer's risk factors
This study uses smartphone tools to track early signs of Alzheimer's by analyzing risk factors. It is for people with mild cognitive issues (MCI) or subjective cognitive decline (SCD) who do not have dementia.
Brescia, BSAges 18 years+ - NCT07730073Recruiting
LSVT-LOUD therapy for voice and speech in Parkinson's disease
This study tests whether LSVT-LOUD, a speech therapy program, can improve voice, speech, and quality of life in people with Parkinson's disease who have voice or speech problems. Participants must be native Turkish speakers, aged 40-80, with mild to moderate Parkinson's.
Kâğıthane, IstanbulAges 40–80 - NCT07729683Recruiting
Testing wakame seaweed for kidney disease patients
This study tests whether eating a daily dose of wakame seaweed can lower certain waste products (AGEs) in your blood that build up with kidney disease. It's for people with moderate chronic kidney disease who are already on standard protective medications.
La RochelleAges 18–90 - NCT07726043Recruiting
Rehab with vibration therapy for balance in CMT1A
This trial tests whether adding a special vibration device to an intensive rehab program helps improve balance in people with Charcot-Marie-Tooth disease type 1A. If you are between 18 and 65 and have mild to moderate leg weakness, you may be able to join.
MarseilleAges 18–65 - NCT05903066Recruiting
MRI-based healing study in Crohn’s disease
This study looks at how Crohn’s disease healing shows up on a special MRI (MRE) and tries to better define what “healed” means. It may help your care team track healing more accurately, especially inside the bowel.
LiègeAges 18–75 - NCT06598878Recruiting
AR-assisted walking training for Parkinson's
This trial tests walking training with augmented reality (AR) goggles to help with movement in Parkinson's disease. It may help improve your gait and balance.
TaoyuanAges 20 years+ - NCT06629194Recruiting
Comparing tests to tell intestinal TB from Crohn's disease
This study looks at different scoring systems to help doctors tell the difference between intestinal tuberculosis (a bacterial infection) and Crohn's disease (a chronic inflammatory condition). If you have ulcers in your ileum or colon and are undergoing a colonoscopy, you may be able to help doctors improve how they diagnose these conditions.
Bangkok Noi, BangkokAges 18 years+ - NCT06631742Recruiting
Exergaming for dementia: a fun exercise trial
This trial tests whether playing interactive video games that combine exercise and thinking challenges (called 'exergaming') can help people with dementia. It aims to see if this fun way to move and think can improve memory, daily function, and quality of life.
Wetzikon, Canton of ZurichAges Any age - NCT05528471Recruiting
Test whether fructose affects fatty liver in teens
This study looks at how fructose (a type of sugar) may affect fatty liver disease (NAFLD) in teens with obesity. The goal is to learn whether fructose changes liver health, using MRI/MRS scans to measure the liver.
Edmonton, AlbertaAges 12–18 - NCT07717411RecruitingPhase 3
Trontinemab for people at risk of Alzheimer's symptoms
This study tests an investigational drug, trontinemab, in people who are cognitively healthy but have a blood marker suggesting a high chance of developing Alzheimer's symptoms later. The goal is to see if the drug can delay or prevent memory loss.
Irvine, CaliforniaAges 55–80 - NCT07722546RecruitingPhase 2
Felzartamab for Graves' disease in adults
This study tests an investigational drug called felzartamab to see if it can help control thyroid function in adults with Graves' disease. It may offer a new option if you are still having symptoms despite anti-thyroid medication.
Glendale, ArizonaAges 18–75 - NCT06598891Recruiting
Balance training for Parkinson's disease
This study tests a special balance training program for people with Parkinson's disease. It aims to see if it can improve walking and reduce falls.
TaoyuanAges 20 years+ - NCT07722637Recruiting
Cardiac rehab's effect on cell health in heart disease
This study looks at whether a heart rehab program can affect a type of cell damage (ferroptosis) in people who recently had heart artery disease. It could help show why rehab is good for recovery.
Kayseri, KayseriAges 18–75 - NCT07719699Recruiting
Vibration and Pilates for chronic low back pain
This study tests if whole-body vibration or Pilates exercises can reduce pain and improve balance and movement in people with long-lasting low back pain. It aims to find a helpful treatment for chronic back pain that has lasted more than 12 weeks.
Lahore, Punjab ProvinceAges 18–40 - NCT07718555Recruiting
Gut bacteria study for autoinflammatory diseases
This study looks at the gut bacteria (microbiome) in people with autoinflammatory diseases. It may help researchers understand how bacteria in the gut affect inflammation and find better ways to treat these conditions.
ParisAges 12 years+ - NCT07715279RecruitingPhase 2
Vericiguat for slowing aortic valve calcium buildup
This trial tests if the drug vericiguat can slow down the buildup of calcium in the aortic valve, which causes it to narrow and stiffen. If you have mild-to-moderate aortic valve stenosis and meet the other criteria, this study may help protect your valve from getting worse.
Chengdu, SichuanAges 35–80 - NCT07721701Recruiting
Digital Dementia Registry for Bavaria
This study follows people with mild cognitive impairment or dementia and their family caregivers over time. It aims to learn more about how these conditions progress and how to improve care, especially for those living in Bavaria.
AschaffenburgAges Any age - NCT07718334Recruiting
Can a medication reminder app improve sticking to treatment?
This study tests whether a mobile app that reminds you to take your medicine can help people who have both chronic health conditions and memory problems stick to their treatment plan. A nurse leader will help guide the program, and you or a caregiver will use the app on a smartphone.
Gamasa, Dakahlia GovernorateAges 18 years+ - NCT07717723Recruiting
Support for caregivers of heart disease patients
This study tests a program to help caregivers of people with heart disease manage stress and challenges. It aims to support your mental health while caring for a loved one.
Sacramento, CaliforniaAges 18 years+ - NCT07716397Recruiting
MRI study for thyroid eye disease diagnosis and care
This study uses MRI scans of the eye area to better understand and classify thyroid eye disease (TED). It aims to help doctors predict outcomes and personalize treatment. You may be eligible if you have stable TED or are a healthy volunteer.
Shanghai, Huangpu DistrictAges 18–75 - NCT07721688Recruiting
Different frequency brain stimulation for Parkinson's disease
This study tests a new, noninvasive brain stimulation technique (called temporal interference stimulation) given at different frequencies. It aims to improve Parkinson's symptoms by gently stimulating the brain area involved in movement.
Guangzhou, GuangdongAges Any age
Hear when a new General Population (no Specific Condition or Disease) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for general population (no specific condition or disease)?
- Yes. Clin2 currently lists 10,565 recruiting general population (no specific condition or disease) studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a general population (no specific condition or disease) trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a general population (no specific condition or disease) trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.